Back to top

Biomarker Testing Stories

Read these inspiring, true stories of people like you sharing their experiences about the impact molecular profiling has had on their fight against lung cancer.

Jessica was diagnosed with non-small cell lung cancer and learned she was ALK-positive.
Jessica
Biomarker: ALK-positive
Mother and criminal justice educator Read More

Jessica is a single mother of two boys and a criminal justice instructor at a local community college. As a young mother who had never smoked and led a relatively active and healthy lifestyle, she was surprised to learn of her diagnosis of non-small cell lung cancer. During her treatment journey, Jessica learned that she was ALK-positive.

Read More
Shari switched treatments after she tested EGFR-positive for her stage-IV NSCLC.
Shari
Biomarker: EGFR-positive
Retired kindergarten teacher, mother and grandmother Read More

Shari is a retired kindergarten teacher, mother and grandmother, who enjoys singing and going to her grandchildren’s sporting events. She had bronchitis, but her doctors couldn’t find anything wrong until they did a CT scan and found stage-IV NSCLC. Shari started chemo but then switched treatments after she tested EGFR-positive.

Read More
Bonnie, a lung cancer patient, started a foundation that educates on early detection as well as biomarker testing.
Bonnie
Biomarker: Unknown
Founder and President of the Bonnie J. Addario Lung Cancer Foundation Read More

Bonnie was a businesswoman and president of a local petroleum distributor when she learned about her lung cancer 6 years ago. And although she was diagnosed in the pre-molecular testing era, Bonnie is in the process of getting her molecular profile. She encourages others to do the same.

Read More
Meryl discovered that her non-small cell lung cancer was ALK-positive.
Meryl
Biomarker: ALK-positive
Wife, mother, therapist and management consultant Read More

Prior to being diagnosed with NSCLC, Meryl was a therapist, management consultant, mother, and wife with a healthy lifestyle. A two-time lung cancer survivor, she underwent surgery and chemotherapy in 2003, and another surgery in 2012 when her cancer recurred. Meryl is glad she had her tumor tested because it could lead to more treatment options in the future.

Read More
Randy, a non-smoker, learned he had Stage III NSCLC.
Randy
Biomarker: Unknown
Entrepreneur, author, husband and father Read More

Randy is an entrepreneur, author, husband, and father. Four years ago, he learned he had Stage III NSCLC. As a non-smoker with no family history of the disease, this came as quite a shock. Following surgery and rounds of chemo and radiation, Randy’s lungs are clear. But he says that if the cancer ever returns, it will be a priority to get his tumor tested.

Read More
Jane was diagnosed with advanced NSCLC and treated with medicine for EGFR-positive mutation.
Jane
Biomarker: EGFR-positive
Wife, mother and grandmother with a passion for travel Read More

Jane is an active wife, mother, and grandmother whose passion is world travel. After several misdiagnoses for her chest pain and cough, a CT scan showed a mass in her left lung, and she learned she had advanced NSCLC. Following an initial course of chemo, molecular testing revealed her tumor was EGFR-positive. She is being treated with a medicine directed at that mutation.

Read More
Laura was prescribed a biomarker-directed therapy for her EGFR-positive Stage IIIB/IV lung caner.
Laura
Biomarker: EGFR-positive
Graphic designer and artist Read More

Laura is a graphic designer and artist who was diagnosed with Stage IIIB/IV adenocarcinoma in her left lung in December of 2007. After having her biopsy tissue sent for molecular testing, she learned she was EGFR-positive and is on a biomarker-directed therapy for that mutation.

Read More
Tom's lung cancer was tested for biomarkers and he learned he was ALK-positive.
Tom
Biomarker: ALK-positive
Husband and patient advocate Read More

Tom was first diagnosed with lung cancer in 2005 while he was training for his 50th marathon. A CAT scan for another ailment revealed a spot on his lung. Five years after surgery, radiation, and chemo, the cancer returned. When Tom’s tumor was tested for biomarkers, he learned he was ALK-positive.

Read More
Jeff was diagnosed with Stage 1b non-small cell lung cancer.
Jeff
Biomarker: Unknown
Vice President at construction company and advocate Read More

Jeff was 46 years old when he was diagnosed with Stage 1b non-small cell andenocarcinoma. After undergoing surgery and chemotherapy, Jeff showed no evidence of disease; however, a regular scan later showed he had developed new tumors. At both diagnoses, his doctors tested his tumors for biomarkers, but tests showed no known biomarkers each time. Jeff is confident that he is on the best treatment for his cancer as a result of these tests.

Read More
Tests revealed Tori had ROS1-positive NSCLC.
Tori
Biomarker: ROS1-positive
Wife, mother and brewery owner Read More

Tori is a wife, mother and active member of her local theater community with Stage 4 NSCLC. Since she had never smoked and does not have a family history of lung cancer, she was confused about her diagnosis and requested biomarker testing. These tests revealed Tori was ROS1-positive.

Read More
Zheng discovered her non-small cell lung cancer was EGFR-positive.
Zheng
Biomarker: EGFR-positive
Opera singer Read More

When she was diagnosed with NSCLC 2 years ago, Zheng was a performer with the San Francisco Opera. After developing resistance to her treatments, her oncologist decided she should get tested for her molecular profile. She tested positive for the EGFR biomarker and started a new treatment plan.

Read More
Jill learned her advanced lung cancer was EGFR-positive.
Jill
Biomarker: EGFR-positive
Mother, sales executive and lung cancer advocate Read More

Jill is a mother of four and a part-time sales executive who is a passionate lung cancer advocate due to a family history with the disease. After proactive annual baseline checkups, she too received a lung cancer diagnosis. Her cancer was EGFR-positive. More recently Jill recurred with advanced lung cancer, but she remains hopeful.

Read More